Previous studies have drawn conflicting conclusions on the role of CCR7+ DCs in tumours; Loss of TIM-3 in DCs prevents the acquisition of this DC activation programme, but facilitates maintenance of the effector CD8+ T cell pool62. The gene discussed is CCR7; the disease is neoplasm.